Speech-Language Pathologists in Lakeway, TX Accepting Medicare

17 Speech-Language Pathologists found. Showing 1 - 17

Ana M Duque, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 15303 Kollmeyer Dr, Lakeway, TX 78734 Phone: 512-533-7910

Kristi Dawn Payton, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 607 Ranch Road 620 N, Lakeway, TX 78734 Phone: 512-533-7961

Newman Speech And Consulting, Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1150 Lakeway Dr Ste 205, Lakeway, TX 78734 Phone: 512-826-4111    Fax: 833-281-1584

Weronika Monaco Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 15303 Kollmeyer Dr, Lakeway, TX 78734 Phone: 512-533-6300

Douglas Flynn Schneider, SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 300 Medical Pkwy, Lakeway, TX 78738 Phone: 512-589-1104

Nicole Rachel Parson Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 15303 Kollmeyer Dr, Lakeway, TX 78734 Phone: 512-533-6030

Leah Foster Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2000 Medical Dr, Lakeway, TX 78734 Phone: 512-263-4568

Jill Barada, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2000 Medical Dr, Lakeway, TX 78734 Phone: 512-759-6438

Mrs. Ashley Chambers, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 107 Bella Strada Cv, Lakeway, TX 78734 Phone: 307-421-3797

Kristen Torres, SPEECH PATHOLOGIST Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2000 Medical Dr, Lakeway, TX 78734 Phone: 512-263-4500

Mrs. Brooke Elizabeth Woolever, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 Medical Pkwy Ste 260, Lakeway, TX 78738 Phone: 737-237-0016

Bianca Ann Lopez-weeks Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 15303 Kollmeyer Dr, Lakeway, TX 78734 Phone: 512-533-7915

Madisyn Elyse Clausen, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2000 Medical Dr, Lakeway, TX 78734 Phone: 512-263-4500

Brendy Elson, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2000 Medical Dr, Lakeway, TX 78734 Phone: 512-759-6038

Rachel Obstfeld Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2000 Medical Dr, Lakeway, TX 78734 Phone: 512-263-4500

Stephanie Wise, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1202 Lakeway Dr Ste 6a, Lakeway, TX 78734 Phone: 512-261-3584

Mrs. Kathryn Burke Mcwilliams, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1202 Lakeway Dr Ste 6a, Lakeway, TX 78734 Phone: 512-261-3584    Fax: 512-524-3649

News Archive

Endobronchial ultrasound: More precise and less invasive than other lung cancer staging methods

A new technique being used by thoracic surgeons at Rush University Medical Center offers a more precise, less invasive and more versatile way of assessing a patient's lymph nodes and chest tumors to determine if lung cancer has spread to other parts of the body.

Anthem Blue Cross of California raises rates as much as 39 percent

Los Angeles Times: "California's largest for-profit health insurer is moving to dramatically raise rates for customers with individual policies, setting off a furor among policyholders and prompting state insurance regulators to investigate.

FDA grants Emergent Fast Track Designation for AVP-21D9 anthrax monoclonal antibody development program

Emergent BioSolutions Inc. announced today that its anthrax monoclonal antibody development program investigating AVP-21D9 for the treatment of inhalational anthrax has been granted Fast Track Designation by the U.S. Food and Drug Administration (FDA). Emergent recently commenced a Phase I clinical trial for AVP-21D9, which is a fully human monoclonal antibody product candidate being developed as a parenteral post-exposure therapeutic to treat symptoms of inhalational anthrax disease.

New drug can alleviate the side effects of tricyclic antidepressants

About one in five Danes are affected by depression at some point in their lives. The severe depressions may be treated with the so-called 'tricyclic antidepressants', an antidepressant drug that is more effective than the drugs used for mild and moderate depressions.

PSU researcher to identify the behavioral health needs of parents with NICU babies

Thirteen years ago, Susanne Klawetter gave birth to triplets. They required a stay in a neonatal intensive care unit. Stays like Klawetter's are relatively common: about 10 percent of all babies born nationwide will require care in a NICU, according to the National Institutes of Health.

Read more Medical News

› Verified 1 days ago